BATS BZX Real-Time Price
As of 3:34pm ET
| -0.01 / -0.11%|
The 5 analysts offering 12-month price forecasts for Progenics Pharmaceuticals Inc have a median target of 11.00, with a high estimate of 12.00 and a low estimate of 11.00. The median estimate represents a +23.73% increase from the last price of 8.89.
The current consensus among 5 polled investment analysts is to Buy stock in Progenics Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.